An observational study in Adrenal Tumor, Adrenal Disease and Adrenal Mass, sponsored by University Hospital Olomouc. Recruiting at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-22.
Sponsored by University Hospital Olomouc · Observational
The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are:
657 studies on the registry are indexed under Adenoma; 98 are open to participants now.
This study's planned enrollment of 100 is below the median of 300 across 226 observational studies indexed under Adenoma.
Browse Adenoma studies →University Hospital Olomouc is the lead sponsor of 40 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients indicated for adrenalectomy based on endocrinological and imaging examination. All patients older than 18 years who met the clinical criteria.
Exclusion Criteria:
Initial examination 1
Initial examination by a urologist and indication for the surgery.
Time frame: 1 day
Initial examination 2
Sampling of biological material: Hemoglobin g/l
Time frame: 1 day
Surgical period 1
Measuring the operation time in minutes.
Time frame: 1 day
Surgical period 2
Measuring the blood loss in milliliters (ml).
Time frame: 1 day
Surgical period 3
Record the need for conversion to open surgery.
Time frame: 1 day
Surgical period 4
Record the surgical complications.
Time frame: 1 day
Surgical period 5
The consumption of special surgical instruments.
Time frame: 1 day
Perioperative period 1
Perioperatively, the length of stay in the ICU in days.
Time frame: from 3- 7 days
Perioperative period 2
Perioperatively, total hospitalization time in days
Time frame: from 3- 7 days
Perioperative period 3
Perioperatively, blood loss from the drain in mililiters (ml).
Time frame: from 3- 7 days
Perioperative period 4
Perioperatively, time to remove the abdominal drain in days.
Time frame: from 3- 7 days
Perioperative period 5
Perioperatively, need for blood substitutes.
Time frame: from 3- 7 days
Perioperative period 6
Perioperatively, number of forced surgical revisions.
Time frame: from 3- 7 days
Perioperative period 7
Perioperatively, consumption of analgesics during the hospitalization.
Time frame: from 3- 7 days
First post-operative check-up 1
First postoperative visit (14th to 20th postoperative day), sampling of biological material: Hemoglobin g/l
Time frame: 1 day of examination, 14- 20 days from the surgery
First post-operative check-up 2
First postoperative visit (14th to 20th postoperative day)- an analysis of perioperative and early postoperative complications according to the Dindo Clavien classification
Time frame: 1 day of examination, 14- 20 days from the surgery
First post-operative check-up 3
First postoperative visit (14th to 20th postoperative day)- necessary hospitalizations and operative revisions.
Time frame: 1 day of examination, 14- 20 days from the surgery
Second post-operative check-up 1
Second postoperative visit (85th to 100th postoperative day)- an analysis of late postoperative complications according to the Dindo Clavien classification.
Time frame: 1 day of examination, 85-100 days from the surgery
Second post-operative check-up 2
Second postoperative visit (85th to 100th postoperative day)- necessary hospitalizations and operative revisions
Time frame: 1 day of examination, 85-100 days from the surgery
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Olomouc